AB
CUE icon

Amalgamated Bank’s Cue Biopharma CUE Stock Holding History

Amalgamated Bank’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-39
Closed -$2K – 3035
2024
Q1 		$2K Sell
39
-124
-76% -$8.75K ﹤0.01% 2880
2023
Q4 		$13K Sell
163
-12
-7% -$858 ﹤0.01% 2802
2023
Q3 		$12K Hold
175
– – ﹤0.01% 2851
2023
Q2 		$19K Buy
+175
New +$20.6K ﹤0.01% 2761
2022
Q2 		– Sell
-168
Closed -$25K – 3069
2022
Q1 		$25K Buy
+168
New +$35.6K ﹤0.01% 2732

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Amalgamated Bank's CUE Position: Q2 2024 in Review

Amalgamated Bank sold out of Cue Biopharma (CUE) in Q2 2024, closing a stake of 39 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in CUE in Q1 2022 and held it in 5 quarters. The position peaked at $25K in Q1 2022. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2024.

  • Amalgamated Bank reported no remaining Cue Biopharma position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 39 Cue Biopharma shares in Q2 2024, an estimated $2K.
  • Amalgamated Bank first reported a position in Cue Biopharma in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Cue Biopharma position peaked at $25K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.